Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.75p
   
  • Change Today:
      0.40p
  • 52 Week High: 12.50p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 19,413,982
  • Market Cap: £13.69m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

Key Personnel

Group Chief Executive: Greg Madison
Independent Non-Executive Director: Anders Lundstrom
Independent Non-Executive Director: Fabiana Lacerca Allen
Independent Non-Executive Director: Peter Llewellyn-Davies
Non-Executive Chairman: Hans-Peter Hasler
Non-Executive Dir: Christian Schweiger

Contact Details

Address: Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Phone: +44 (0) 191 511 8500
Website: http://www.shieldtherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYV81293

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 1.75p
Change Today 0.40p
% Change 29.63 %
52 Week High 12.50p
52 Week Low 1.23p
Volume 19,413,982
Shares Issued 782.06m
Market Cap £13.69m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.57% below the market average44.57% below the market average44.57% below the market average44.57% below the market average44.57% below the market average
37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average
Price Trend
95.85% below the market average95.85% below the market average95.85% below the market average95.85% below the market average95.85% below the market average
96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average
Income Not Available
Growth
59.09% above the market average59.09% above the market average59.09% above the market average59.09% above the market average59.09% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
16:29 78,690 @ 1.74p
16:22 1,500,000 @ 1.70p
16:21 75,000 @ 1.79p
16:21 100,000 @ 1.78p
16:20 150,000 @ 1.79p

Top of Page